Eucrates Biomedical Acquisition Corp. logo
Eucrates Biomedical Acquisition Corp. EUCR
$ 10.04 0.0%

Eucrates Biomedical Acquisition Corp. Balance Sheet 2011-2024 | EUCR

Annual Balance Sheet Eucrates Biomedical Acquisition Corp.

2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Net Debt

- - - - - - - - - - - -

Long Term Debt

- - - - - - - - - - - -

Long Term Debt Current

- - - - - - - - - - - -

Total Non Current Liabilities

- - - - - - - - - - - -

Total Current Liabilities

65.1 K 38.5 K - - - - - - - - - -

Total Liabilities

3.95 M 5.8 M - - - - - - - - - -

Deferred Revenue

- - - - - - - - - - - -

Retained Earnings

-3.72 M -5.49 M - - - - - - - - - -

Total Assets

12.5 M 105 M - - - - - - - - - -

Cash and Cash Equivalents

18.9 K 49.2 K 551 K - - - - - - - - -

Book Value

8.54 M 99.3 M - - - - - - - - - -

Total Shareholders Equity

-3.72 M -5.49 M -9.31 M - - - - - - - - -

All numbers in USD currency

Quarterly Balance Sheet Eucrates Biomedical Acquisition Corp.

2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Long Term Debt

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Non Current Liabilities

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Liabilities

- 3.93 M 4.11 M 4.55 M 5.8 M 6.27 M 7.46 M 8.23 M 10.3 M 10.3 M 10.3 M 10.3 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Deferred Revenue

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Retained Earnings

- -3.73 M -3.79 M -4.16 M -5.49 M -5.74 M -2.3 M -2.93 M -9.31 M -9.31 M -4.92 M -4.92 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Assets

- 106 M 105 M 105 M 105 M 105 M 106 M 106 M 106 M 106 M 106 M 106 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Cash and Cash Equivalents

- 60 K 105 K 159 K 49.2 K 206 K 383 K 443 K 551 K 551 K 551 K 551 K - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Book Value

- 102 M 101 M 101 M 99.3 M 99.1 M 98.1 M 97.5 M 95.5 M 95.5 M 95.5 M 95.5 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Shareholders Equity

- -3.73 M -3.79 M -4.16 M -5.49 M -5.74 M -6.69 M -7.32 M -9.31 M -9.31 M 5 M 5 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency